Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-006520
Filing Date
2020-03-30
Accepted
2020-03-30 16:03:49
Documents
65
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ctdh20191231_10k.htm 10-K 871864
2 EXHIBIT 4.3 ex_179124.htm EX-4.3 30513
3 EXHIBIT 31.1 ex_178834.htm EX-31.1 13800
4 EXHIBIT 31.2 ex_178835.htm EX-31.2 14529
5 EXHIBIT 32.1 ex_178836.htm EX-32.1 5984
6 EXHIBIT 32.2 ex_178837.htm EX-32.2 6104
  Complete submission text file 0001437749-20-006520.txt   4293110

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctdh-20191231.xml EX-101.INS 660176
8 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20191231.xsd EX-101.SCH 59875
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20191231_cal.xml EX-101.CAL 38213
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20191231_def.xml EX-101.DEF 356470
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20191231_lab.xml EX-101.LAB 322612
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20191231_pre.xml EX-101.PRE 381026
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINSVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25466 | Film No.: 20756964
SIC: 2860 Industrial Organic Chemicals